Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Transplantation Immunology”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Looking for participantsNCT06839456
What this trial is testing

Phase 1/2: CD45RA Depleted Stem Cell Addback to Prevent Viral or Fungal Infections Post TCRab/CD19 Depleted HSCT

Who this might be right for
LeukemiaHigh Risk Acute Lymphoblastic LeukemiaHigh Risk Acute Myeloid Leukemia+11 more
Children's Hospital of Philadelphia 100
Testing effectiveness (Phase 2)Ended earlyNCT00090194
What this trial is testing

Improving Transplant Options of Highly Sensitized Recipients Using IGIV-C, 10%

Who this might be right for
Kidney Failure, Chronic
National Institute of Allergy and Infectious Diseases (NIAID) 56
Testing effectiveness (Phase 2)Looking for participantsNCT05470491
What this trial is testing

Trial of Allogeneic Reduced-Intensity, HLA-Haploidentical Allogeneic Hematopoietic Cell Bone Marrow Transplantation Followed by Graft-versus-Host-Disease (GVHD) Prophylaxis With Cyclophosphamide, Bortezomib and Maraviroc for Hematologic Malignancies ...

Who this might be right for
HIVHematologic Malignancies
National Cancer Institute (NCI) 265
Testing effectiveness (Phase 2)UnknownNCT01198314
What this trial is testing

Withdrawal of Immunosuppression in Long Term Stable Liver Transplant Recipients

Who this might be right for
Liver Transplantation
The Catholic University of Korea 20
Not applicableNo Longer AvailableNCT03010332
What this trial is testing

Expanded Access Protocol of ATA230 (Third-Party Donor-Derived CMV-CTLs) for the Treatment of CMV Viremia or Disease

Who this might be right for
CMV ViremiaCMV Disease
Atara Biotherapeutics
Testing effectiveness (Phase 2)Ended earlyNCT01027702
What this trial is testing

Donor Lymphocyte Infusion After Alternative Donor Transplantation

Who this might be right for
Immunodeficiency
Wake Forest University Health Sciences 38
Early research (Phase 1)Ended earlyNCT04310592
What this trial is testing

Natural Killer Cell (CYNK-001) Infusions in Adults with AML

Who this might be right for
LeukemiaLeukemia, MyeloidLeukemia, Myeloid, Acute+17 more
Celularity Incorporated 27
Testing effectiveness (Phase 2)Ended earlyNCT00432419
What this trial is testing

Therapeutic Intensification of HIV-associated Non-Hodgkin's Lymphoma by Peripheral Blood Cell Transplantation Following Chemotherapy.

Who this might be right for
HIV InfectionsLymphoma, Non-Hodgkin
French National Agency for Research on AIDS and Viral Hepatitis 1
Testing effectiveness (Phase 2)Study completedNCT00576407
What this trial is testing

Thymus Transplantation in DiGeorge Syndrome #668

Who this might be right for
DiGeorge SyndromeComplete Typical DiGeorge Anomaly
Sumitomo Pharma Switzerland GmbH 26
Testing effectiveness (Phase 2)Active Not RecruitingNCT04904588
What this trial is testing

HLA-Mismatched Unrelated Donor Hematopoietic Cell Transplantation With Post-Transplantation Cyclophosphamide

Who this might be right for
Acute Lymphoblastic LeukemiaAcute Myelogenous LeukemiaMixed Phenotype Acute Leukemia+5 more
Center for International Blood and Marrow Transplant Research 300
Testing effectiveness (Phase 2)Ended earlyNCT01182675
What this trial is testing

Hematopoietic Stem Cell Transplantation (HSCT) for Children With SCID Utilizing Alemtuzumab, Plerixafor & Filgrastim

Who this might be right for
Severe Combined Immunodeficiency
University of California, San Francisco 7
Not applicableNot Yet RecruitingNCT06988072
What this trial is testing

Study of Anti-BKPyV Immune Responses in Kidney Transplant Patients With BKPyV Viremia

Who this might be right for
BK PolyomavirusKidney Transplant
Assistance Publique - Hôpitaux de Paris 75
Not applicableStudy completedNCT00839709
What this trial is testing

Peripheral Immunologic Response of Solid Organ Transplant Recipients to Depletion Versus Non-depletion Protocols

Who this might be right for
Liver DiseaseLiver Transplantation
University of Washington 30
Large-scale testing (Phase 3)Looking for participantsNCT03818334
What this trial is testing

Post Transplant Cyclophosphamide in Matched Unrelated Donor Stem Cell Transplantation for Hematological Malignancies

Who this might be right for
Bone Marrow Transplant ComplicationsGraft Versus Host DiseaseInfection Viral+2 more
Hospital Israelita Albert Einstein 50
Early research (Phase 1)Enrolling By InvitationNCT06508138
What this trial is testing

Clinical Trial Assessing the Safety and Immunologic Correlates of Heterologous Prime-Boost With pNGVL4a-Sig/E7(Detox)/HSP70 and TA-HPV in Healthy Donors Followed by Peripheral Blood Collection

Who this might be right for
HPV 16 InfectionHPV-Related CarcinomaRecurrence+1 more
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 24
Large-scale testing (Phase 3)Study completedNCT02327351
What this trial is testing

TCR Alpha/Beta Depletion for HSCT From Haploidentical and Unrelated Donors in the Treatment of PID

Who this might be right for
Primary Immune Deficiency DisorderHematopoietic Stem Cell Transplantation
Federal Research Institute of Pediatric Hematology, Oncology and Immunology 98
Not applicableStudy completedNCT05298930
What this trial is testing

Feasibility Study to Assess an Adapted Physical Activity Program in Children, Adolescents and Young Adults Requiring Hematopoietic Stem Cell Transplantation

Who this might be right for
Haematological MalignancyAcute LeukemiaMyelodysplastic Syndromes+3 more
Centre Leon Berard 15
Testing effectiveness (Phase 2)Study completedNCT00579527
What this trial is testing

Phase I/II Thymus Transplantation With Immunosuppression #950

Who this might be right for
DiGeorge AnomalyComplete DiGeorge AnomalyComplete Atypical DiGeorge Anomaly+2 more
Sumitomo Pharma Switzerland GmbH 14
Not applicableUnknownNCT03425071
What this trial is testing

Monitoring Concentration and Pharmacodynamic Effects of Tacrolimus in Peripheral Blood Lymphocytes of Kidney Transplant Recipients

Who this might be right for
Kidney TransplantationRejection
University of Sao Paulo General Hospital 45
Testing effectiveness (Phase 2)UnknownNCT02061800
What this trial is testing

CD34+ (Malignant) Stem Cell Selection for Patients Receiving Allogenic Stem Cell Transplant

Who this might be right for
Chronic Myeloid Leukemia (CML)Acute Myelogenous Leukemia (AML)Myelodysplastic Syndrome (MDS)+3 more
Diane George 14
Next Page